| Terminated | 1b/2a | 50 | US | PLX51107 | Plexxikon | Solid Tumors, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma | 09/18 | 09/18 | | |
NCT04910152: Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD |
|
|
| Terminated | 1/2 | 2 | US | BRD4 Inhibitor PLX51107, PLX 51107, PLX-51107, PLX51107 | Hannah Choe, MD, Plexxikon, National Cancer Institute (NCI) | Acute Graft Versus Host Disease, Steroid Refractory Graft Versus Host Disease | 09/23 | 09/23 | | |
